Published • loading... • Updated
AbbVie Earnings Preview: Immunology Portfolio Remains in Focus Amid Humira Decline
Summary by Seeking Alpha
3 Articles
3 Articles
3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st
AbbVie's two newest drugs are growing so fast they've rewritten the company's entire story, and Wall Street may not have fully priced in what happens when the July 31 earnings report confirms it.
·Lakewood, United States
Read Full Article
Goldman Sachs uncovers key AbbVie stock signals before earnings
AbbVie(ABBV) reports second-quarter results on Friday, July 31, and the mood around the stock has changed. A few months ago, investors were restless. The two drugs carrying the company were doing fine, but everyone already knew that, and the market…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
